Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by François‐Emery Cotte
Evaluatio N of a Pi X Aban in STR O Ke and Systemic Embolism Prevention in Patients With Non‐valvular Atrial Fibrillation in Clinical Practice S Etting in France, Rationale and Design of the NAXOS: SNIIRAM Study
Clinical Cardiology
Medicine
Cardiovascular Medicine
Cardiology
Related publications
Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation
Heart and Vessels
Cardiovascular Medicine
Cardiology
Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Characteristics and 12-Month Outcomes of Patients With Valvular and Non-Valvular Atrial Fibrillation in Kenya
PLoS ONE
Multidisciplinary
Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCV7 a Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients With Non-Valvular Atrial Fibrillation (NVAF)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Pcv75 - An Updated Cost-Effectiveness Pairwise Analysis of Apixaban and Warfarin for Stroke Prevention in Patients With Non- Valvular Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Clinical Analysis of Antithrombotic Treatment and Occurrence of Stroke in Elderly Patients With Non-Valvular Persistent Atrial Fibrillation
Clinical Cardiology
Medicine
Cardiovascular Medicine
Cardiology
